Article
Evaluation of α‐synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
18 Nov 2016
Abstract excerpt
INTRODUCTION: Accurate diagnosis of prion diseases and discrimination from alternative dementias gain importance in the clinical routine, but partial overlap in cerebrospinal fluid (CSF) biomarkers impedes absolute discrimination in the differential diagnostic context. METHODS: We established the clinical parameters for prion disease diagnosis for the quantification of CSF α-synuclein in patients with sporadic (n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
